Compare Ishares Msci Thailand Etf (THD) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Thailand Etf vs TransMedics Group Inc — how do they compare? Ishares Msci Thailand Etf trades at $73.43, while TransMedics Group Inc trades at $73.5 (market cap $2.54B). The key difference: Ishares Msci Thailand Etf is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| THD | TMDX | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $75.05 | $150.42 |
52-Week Low | $55.83 | $61.99 |
Market Cap | — | $2.54B |
Enterprise Value | — | $2.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
THD trades at $73.02, up 0.21% on the day, with a bullish technical outlook supported by moving averages, though the 6-day RSI indicates overbought conditions. The stock lacks disclosed fundamental ratios, but recent dividend activity includes a $1.71 per share payment scheduled for June 2026. News highlights THD's strong performance among ASEAN ETFs, driven by exposure to AI hardware plays like Delta Electronics.
Outlook is cautiously optimistic given technical strength and AI-driven tailwinds, but risks include concentrated holdings and profit-taking vulnerability. Investors should weigh the bullish trend against high RSI levels and reliance on specific sectors for future gains.
TransMedics (TMDX) is trading at $73.47, down 0.69% on the day, amid a mixed technical and fundamental backdrop. The stock shows neutral technical signals with support near $72 and resistance at $75, while fundamentals are strong with a trailing P/E of 16.81 and robust profitability metrics like a 27.04% net income margin. Recent earnings saw a Q1 2026 miss but beats in prior quarters, and the company is expanding in Europe through strategic investments.
The outlook is cautiously optimistic with a consensus price target of $108.71 implying significant upside, supported by 75% analyst buy ratings. Key risks include margin pressure from expansion costs and competitive threats, but the company's organ transplant logistics network offers a durable competitive advantage for long-term growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ishares Msci Thailand Etf
THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
